semaglutide phase 3 nash for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers ESSENCE Phase 3 trial results – Two Years on Semaglutide -

It may reduce skin pigmentation and enhance the overall appearance of the skin

resolve ALI/ARDS with related vessel permeability issues

For example, Senators Jim Banks of Indiana and Thom Tillis of North Carolina have both sent letters to the FDA expressing their concern over the proliferation of injectable weight-loss drugs compounded using tainted APIs imported from China, India, and other countries and calling on the agency to do more to address the growing public health threat posed by counterfeit and illegally imported GLP-1[s]. 38 The FDA must step up enforcement of the laws already on the books to put a stop to these dangers

Safety outcomes included mortality and symptomatic intracranial hemorrhage (sICH)

GLP-1 drugs studied included semaglutide (Ozempic, Wegovy), liraglutide, dulaglutide, and tirzepatide

Key takeaways Weight loss may plateau as the body adjusts to Wegovy, typically after six months